InstalabSapovirus V
Should you take a Sapovirus V test?
This test is most useful if any of these apply to you.
About Sapovirus V
Sapovirus can explain some episodes of diarrhea and vomiting, especially in young children, and it can persist in people with weakened immune systems. This test targets genogroup V, one branch of human sapoviruses. Several clinical stool PCR panels already include this branch, so its added value depends on what your earlier testing covered.
A positive result means the assay detected viral genetic material in your stool. Symptoms, other possible causes, and the timing of the sample determine how much weight to give that finding.
What the Test Detects
Sapoviruses belong to the same virus family as norovirus. They spread through contaminated hands, surfaces, food, or water, including contact with stool or vomit. The four established human genogroups are I, II, IV, and V. A genogroup contains related viruses; genogroup V is not a single strain.
This stool test uses qPCR to detect genetic material from genogroup V. Sapovirus carries its genetic instructions as RNA, so PCR detection requires that RNA to be copied into DNA first. Detecting that material does not establish whether the virus is still infectious.
The catalog lists the reporting unit as CFU/g stool. CFU ordinarily refers to colonies grown in culture, while viral qPCR detects genetic material. The laboratory's calibration would need to explain what this reporting label represents. It should not be interpreted as a count of live viruses or converted into the RNA quantities reported in research.
Detecting sapovirus in stool has an established role in diagnosing gastrointestinal infections. Using the quantity from this particular genogroup-specific assay to grade illness, choose treatment, or track recovery remains unvalidated. The cited studies do not establish clinical decision limits in CFU/g stool for this test.
Genogroups I and II account for most typed human infections in many studies. Genogroup V was a minority of sequenced infections in a German hospital study. Its frequency varies by setting: an Osaka study found that GV.1 accounted for nearly 95% of sapovirus sequences in wastewater at its peak, despite being less common in clinical samples. That environmental finding suggests circulation missed by clinical surveillance, but it cannot establish whether an individual infection causes symptoms.
Most clinical studies below measured several sapovirus genogroups together using stool PCR. They describe sapovirus illness broadly and do not validate this assay's genogroup V quantity. Wastewater findings concern a different specimen, and the Australian cohort used stool swabs rather than a weighed stool specimen.
Diarrhea in Babies and Young Children
Young children have the highest burden of sapovirus illness, though adults can be infected too. In a birth cohort of about 1,700 children across eight lower- and middle-income countries, 94% had evidence of infection by age two and about half had diarrhea with sapovirus detected. The virus appeared in about a quarter of diarrheal stools and one in eight routine surveillance stools. Those figures describe the study communities, not every child's chance of infection.
A meta-analysis of 106 studies found sapovirus in about 4% of gastroenteritis cases in children under five and about 7% of cases studied in community settings. Detection was more frequent in studies using qPCR than conventional PCR, though the studies also differed in their populations. A separate analysis of case-control studies found about 80% higher odds of sapovirus detection in children with gastroenteritis than in controls.
In one year of Spanish outpatient testing, sapovirus was detected in about one in six people with gastroenteritis and was second to norovirus among the viral causes assessed. This was a local estimate across sapovirus genogroups. It does not imply that genogroup V causes one in six cases.
As rotavirus vaccination has reduced rotavirus illness, sapovirus has become a more prominent part of the remaining childhood gastroenteritis burden.
Cancer Treatment and Transplants
Sapovirus can cause persistent diarrhea in people with weakened immune systems. In one adult oncology study, it was detected in fewer than 1% of all people tested, but accounted for about one in ten people with a viral pathogen detected. A subset of transplant recipients had prolonged positive stool tests, with a median detection period of 97 days and a maximum of 495 days. These were findings from a qualitative panel covering multiple genogroups, not measurements of genogroup V concentration.
After a stem cell transplant, graft-versus-host disease can also cause diarrhea. In this condition, donor immune cells attack your tissues, including the gut. Medication effects and other infections are additional possibilities. Finding sapovirus does not exclude these conditions or establish that an endoscopy or biopsy can be avoided.
Hospital Stays and Mixed Infections
Sapovirus is sometimes found alongside other intestinal pathogens. In the eight-country cohort, sapovirus-positive stools had about 60% higher odds of containing rotavirus, about 50% higher odds for astrovirus, and about 40% higher odds for Shigella. Shared exposure or susceptibility could contribute to these associations; they do not prove that one infection causes another.
In South African children hospitalized for diarrhea, sapovirus was detected in about one in thirteen admissions and in 9 of 79 children who died. Those detections do not establish that sapovirus caused the deaths, and the findings were not specific to genogroup V. When several pathogens are detected, each result needs to be assessed against the symptoms and exposure history.
Immunity After a First Infection
Birth-cohort studies found that earlier sapovirus infection was associated with a lower chance of another infection or illness. They measured different outcomes, so their estimates should not be treated as interchangeable.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 1,700 children in eight countries, followed to age two | Prior sapovirus infection versus none, using stool PCR | About a fifth lower risk of another detected infection and about a quarter lower risk of diarrhea with sapovirus detected |
| 158 Australian children, followed to age two | Prior sapovirus infection versus none, using weekly stool swabs | About 30% lower risk of another detected infection after adjustment for other risk factors |
| 444 Nicaraguan children enrolled at birth and followed to age three | A first sapovirus illness versus no previous episode, using stool PCR | About two thirds lower risk of another sapovirus illness in an analysis designed to account for differences in susceptibility |
Studies that identified the viral genotype found that repeat infections usually involved a different type. This suggests some type-specific protection, but does not establish how much protection an earlier infection provides against genogroup V. Reinfection remains possible.
Reading a Positive Result
Sapovirus RNA can be detected during illness, after recovery, or in someone without symptoms. Across studies, about 3% of people without gastroenteritis symptoms tested positive for sapovirus. A compatible illness makes the finding more relevant, but a positive result alone cannot establish the cause of your symptoms.
Some studies found more viral RNA in diarrheal stools than in stools collected without diarrhea. A Peruvian study found this pattern using PCR cycle measurements. A Dutch case-control study found that cycle measurements did not reliably distinguish illness from symptom-free detection. Neither study established how to interpret this assay's CFU/g stool result, so a larger number is not a validated measure of severity or proof of causation.
When Results Can Be Misleading
- Shedding after recovery: viral RNA can remain detectable for weeks after symptoms clear, and sometimes for months with immune suppression. A positive result cannot determine whether you are still contagious.
- False positives and inconsistent weak signals: contamination or assay-specific errors can produce a positive result. In one study of a different commercial panel, about one in five sapovirus-positive specimens did not meet confirmation criteria using reference methods. That finding cannot be used as this assay's false-positive rate.
- Missed variants: genetic changes in the region targeted by PCR can prevent detection. A Swedish outbreak involved a genogroup V variant missed by the routine PCR methods used at the time. It does not establish how this assay performs against that variant.
- Sample and reaction problems: too little viral material, breakdown of RNA during unsuitable storage, or substances in stool that interfere with PCR can cause a negative result despite infection.
- Comparing quantities: extraction, calibration, specimen preparation, and the genetic region targeted differ between assays. Results from different laboratories, qualitative panels, and research RNA measurements are not directly interchangeable.